RÉSUMÉ DIGEST
ACT 219 (SB 28) 2018 Regular Session Mills
Prior law provided that pharmaceutical manufacturers who engage in marketing directly to
a prescriber may inform the prescribers of an internet website containing prescription drug
price information.
New law exempts veterinarians and certain pharmaceutical marketers of prescription drugs
manufactured exclusively for nonhuman consumption from the provisions established in
prior law regarding disclosure of prescription drug price information.
Prior law required prescribers to access the prescription drug monitoring program prior to
initially prescribing an opioid and every 90 days if the course of treatment continues.
New law exempts veterinarians from accessing the prescription monitoring program prior
to prescribing an opioid and every 90 days if the course of treatment continues.
Prior law required prescribers of controlled dangerous substances to obtain three credit hours
of continuing education on drug diversion training, best practice prescribing of controlled
substances, appropriate treatment for addiction, and other matters deemed relevant by their
respective licensing board.
New law exempts veterinarians from continuing education requirements for prescribers of
controlled dangerous substances.
Effective August 1, 2018.
(Adds R.S. 37:1251(D) and R.S. 40:978(F)(3) and 978.3(E))